Guðlaugur Eyjólfsson
Guðlaugur Eyjólfsson is the director of the Alzheimer's Society in Iceland, who has expressed cautious optimism about the approval of the Alzheimer's drug Leqembi, emphasizing the need for careful consideration of the patient population that may benefit from the medication.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Iceland:
Guðlaugur Eyjólfsson, the director of the Alzheimer's Association, states that it is significant news that Leqembi has received marketing authorization in Iceland.
7